Zivo Bioscience, Inc. (ZIVO): Cash & Equivalents
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
Older than the company's other figures. The latest Cash & Equivalents is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2024-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$1.80M
As of 2022-12-31
+73.2%
3-year compound annual growth
+41.5%
5-year compound annual growth
+43.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $1.80M | -79.8% | 2023-03-14, Balance as of period end |
| 2021-12-31 | $8.90M | n/m | 2023-03-14, Balance as of period end |
| 2020-12-31 | $137.9K | -60.2% | 2022-04-22, Balance as of period end |
| 2019-12-31 | $346.1K | -11.0% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $388.9K | +22.6% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $317.1K | -37.4% | 2019-02-12, Balance as of period end |
| 2016-12-31 | $507.0K | n/m | 2018-02-21, Balance as of period end |
| 2015-12-31 | $16.6K | n/m | 2017-03-31, Balance as of period end |
| 2014-12-31 | $1.4K | -99.7% | 2015-04-06, Balance as of period end |
| 2013-12-31 | $493.1K | +945.9% | 2015-04-06, Balance as of period end |
| 2012-12-31 | $47.1K | -79.1% | 2014-03-31, Balance as of period end |
| 2011-12-31 | $225.7K | n/m | 2013-03-25, Balance as of period end |
| 2010-12-31 | $15.6K | n/a | 2012-03-30, Balance as of period end |